Also known as آسٹیوپوروسس مینجمنٹ
Immunologist
M.B.B.S., Fellow of the American Academy of Allergy Asthma and Immunology (FAAAAI), Diplomat American Board of Internal Medicine, Diplomat American Board of Allergy & Immunology
Immunologist
M.B.B.S., Fellow of the American Academy of Allergy Asthma and Immunology (FAAAAI), Diplomat American Board of Internal Medicine, Diplomat American Board of Allergy & Immunology
Internal Medicine Specialist
M.B.B.S., M.D (Medicine)
Pathologist
M.B.B.S., M.Phil Pathology (Hematology), Certified in Diabetes, CHPE
Gastroenterologist
M.B.B.S., F.C.P.S. (Gastroenterology)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), F.C.P.S (Gastroenterology)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), F.C.P.S (Gastroenterology)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine)
Internal Medicine Specialist
MBBS, PLAB (UK), FCPS (Gastroenterology)
Gastroenterologist
M.B.B.S., M.C.P.S, F.C.P.S., M.R.C.P
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures